Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Melina E. Marmarelis"'
Autor:
William Tompkins, MD, Connor B. Grady, MPH, Wei-Ting Hwang, PhD, Krishna Chandrasekhara, Caroline McCoach, MD, Fangdi Sun, MD, Geoffrey Liu, MD, Devalben Patel, MD, Jorge Nieva, MD, Amanda Herrmann, MD, Kristen Marrone, MD, Vincent K. Lam, MD, Vamsi Velcheti, MD, Stephen V. Liu, MD, Gabriela Liliana Bravo Montenegro, MD, Tejas Patil, MD, Jared Weiss, MD, Kelsey Leigh Miller, MD, William Schwartzman, MD, Jonathan E. Dowell, MD, Khvaramze Shaverdashvili, MD, Liza Villaruz, MD, Amanda Cass, PharmD, Wade Iams, MD, Dara Aisner, MD, PhD, Charu Aggarwal, MD, D. Ross Camidge, MD, PhD, Melina E. Marmarelis, MD, Lova Sun, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 8, Pp 100669- (2024)
Introduction: Characteristics of long-term survivors in EGFR-mutant (EGFRm) NSCLC are not fully understood. This retrospective analysis evaluated a multi-institution cohort of patients with EGFRm NSCLC treated in the pre-osimertinib era and sought to
Externí odkaz:
https://doaj.org/article/0d3a7a8c7ded4bf788294fa0471d93f0
Autor:
Tejas Patil, MD, Alyse Staley, MS, Yunan Nie, MD, Mandy Sakamoto, MD, Margaret Stalker, MD, James M. Jurica, MD, MBA, Kenna Koehler, BA, Amanda Cass, PharmD, Halle Kuykendall, BA, Emily Schmitt, MS, Emma Filar, BA, Evelina Reventaite, MS, Kurt D. Davies, PhD, Hala Nijmeh, PhD, Mary Haag, PhD, Benjamin A. Yoder, PharmD, Paul A. Bunn, MD, Erin L. Schenk, MD, PhD, Dara L. Aisner, MD, PhD, Wade T. Iams, MD, Melina E. Marmarelis, MD, D. Ross Camidge, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 2, Pp 100637- (2024)
Introduction: Acquired MET gene amplification, MET exon 14 skip mutations, or MET fusions can emerge as resistance mechanisms to tyrosine kinase inhibitors (TKIs) in patients with lung cancer. The efficacy and safety of combining MET TKIs (such as cr
Externí odkaz:
https://doaj.org/article/63d7bcf67c604305b7273bb565a9b37b
Autor:
Vivek Nimgaonkar, Charu Aggarwal, Abigail T. Berman, Peter Gabriel, Lawrence N. Shulman, John Kucharczuk, Megan Roy, Joshua M. Bauml, Aditi P. Singh, Roger B. Cohen, Corey J. Langer, Melina E. Marmarelis
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background To ensure safe delivery of oncologic care during the COVID-19 pandemic, telemedicine has been rapidly adopted. However, little data exist on the impact of telemedicine on quality and accessibility of oncologic care. This study ass
Externí odkaz:
https://doaj.org/article/1ef6f2ace7894ea7845b53f27e778e88
Autor:
Xiao Wang, Sharyn Katz, John Miura, Giorgos Karakousis, Leonid Roshkovan, Suzanne Walker, Sally McNulty, Christine Ciunci, Keith Cengel, Corey J. Langer, Melina E. Marmarelis
Publikováno v:
PLoS ONE, Vol 17, Iss 9 (2022)
Background Diffuse malignant peritoneal mesothelioma (DMPM) is a rare variant of malignant mesothelioma, representing 10–15% of malignant mesothelioma cases. The preferred therapeutic approach is cytoreductive surgery (CRS) accompanied by hyperther
Externí odkaz:
https://doaj.org/article/15d3b13be0864d04a63b787258c393a2
Autor:
Roger Y. Kim, MD, Nandita Mitra, PhD, Stephen J. Bagley, MD, MSCE, Melina E. Marmarelis, MD, MSCE, Andrew R. Haas, MD, PhD, Katharine A. Rendle, PhD, MSW, MPH, Anil Vachani, MD, MSCE
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 6, Pp 100188- (2021)
Introduction: Since the July 2017 National Comprehensive Cancer Network (NCCN) malignant pleural mesothelioma (MPM) guideline revision recommended second-line immune checkpoint inhibitors (ICIs), studies have suggested a greater response to ICI among
Externí odkaz:
https://doaj.org/article/f4fe6a2da7b84dab9041ff1a5a42a164
Publikováno v:
Clinical Lung Cancer. 24:235-243
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eaa1a7113e2e0814c77451fd56a07eab
https://doi.org/10.1016/j.cllc.2023.02.007
https://doi.org/10.1016/j.cllc.2023.02.007
Autor:
Wade T. Iams, Meridith L. Balbach, Sharon Phillips, Adrian Sacher, Christine Bestvina, Vamsidhar Velcheti, Xiao Wang, Melina E. Marmarelis, Nan Sethakorn, Ticiana Leal, Paul E. Sackstein, Chul Kim, MD Andrew Robinson, Kathan Mehta, Robert Hsu, Jorge Nieva, Tejas Patil, D. Ross Camidge
Publikováno v:
Clinical Lung Cancer. 24:228-234
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f0585933da6b64806798c73252a8d91
https://doi.org/10.1016/j.cllc.2023.01.009
https://doi.org/10.1016/j.cllc.2023.01.009
Publikováno v:
Journal of Thoracic Oncology. 18:265-267
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe259b41a1b639f3bfbea0e68763da55
https://doi.org/10.1016/j.jtho.2022.12.004
https://doi.org/10.1016/j.jtho.2022.12.004
Publikováno v:
Pharmacoepidemiology and Drug Safety. 31:1121-1126
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93ab09f336a31c1ab89d6b045b72594b
https://doi.org/10.1002/pds.5487
https://doi.org/10.1002/pds.5487
Autor:
Melina E. Marmarelis, Yu-Xiao Yang, Wei-Ting Hwang, Ronac Mamtani, Aditi Singh, Christine Ciunci, Charu Aggarwal, Roger B. Cohen, Corey J. Langer
Publikováno v:
Clin Lung Cancer
MICROABSTRACT: Effective treatment strategies after immunotherapy are greatly needed in NSCLC. The time off platinum chemotherapy (platinum-free-interval) is one predictor used to select patients for platinum re-exposure in other malignancies, but is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::321dc315cdae22801a3af1b0a83f360a
https://doi.org/10.1016/j.cllc.2021.12.009
https://doi.org/10.1016/j.cllc.2021.12.009